Opinion

Video

ADCs Targeting HER2+ GU Cancers

Author(s):

Vijayakrishna Gadi, MD, University of Illinois College of Medicine,Susana Campos, MD, MPH

A panel of experts discuss if there is a role for HER2-directed ADCs antibody-drug conjugates in GU genitourinary cancers

Video content above is prompted by the following:

  • Is there a role for HER2-directed ADCs in GU cancers?
    • What did the primary results from the DESTINY-PanTumor02 trial demonstrate for T-DXd for patients with bladder cancer?Is there a role for HER2-directed ADCs in GU cancers?
Related Videos
2 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
5 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content